DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Abitesartan
Abitesartan
Ovid MEDLINE(R)
(12) Patent Application Publication (10) Pub. No.: US 2015/0202317 A1 Rau Et Al
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
Wo 2011/060945 A2
Pharmaceutical Appendix to the Harmonized Tariff Schedule
Self-Measured Compared to Office
WO 2011/089216 Al
Providing for Duty-Free Treatment for Specified Pharmaceutical Active
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2008) (Rev
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Stembook 2018.Pdf
Significant Beneficial Effect of AT-1 Receptor Blockers (Sartans) in Stroke
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Confidential: for Review Only
SUPPLEMENTARY MATERIAL 1: Search Strategy
Ep 2671584 A2
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Top View
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Review)
Quality Control of Impurities and Comparison of Pharmacokinetic Parameters of Angiotensin Receptor Antagonists
Statistical Analysis Plan: 20140254 Date: 07 January 2017 Page 24
Customs Tariff - Schedule Xxi - 1
First-Line Combination Therapy Versus First-Line Monotherapy for Primary Hypertension (Review)
Beta-Blockers and Inhibitors of the Renin-Angiotensin Aldosterone System for Chronic Heart Failure with Preserved Ejection Fraction (Protocol)
Harmonized Tariff Schedule of the United States (2006) (Rev
(12) Patent Application Publication (10) Pub. No.: US 2009/0306027 A1 Worcel Et Al
Pharmacotherapy for Hypertension in Adults Aged 18 to 59 Years (Review)
Che Roos, Nur Aishah (2019) Antihypertensive Drugs and Risk of Cancer: a Systematic Review and Meta-Analysis of Randomised Controlled Trials
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
An Application to Include Blood Pressure Lowering Drug Fixed Dose
Pharmaceuticals Appendix
Olmesartan Medoxomil
3011 January 1997 U.S
Drugs for Primary Prevention of Atherosclerotic Cardiovascular Disease: an Overview of Systematic Reviews
(12) Patent Application Publication (10) Pub. No.: US 2009/0012057 A1 Garvey (43) Pub